News
ZBH
107.12
+1.24%
1.31
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Simply Wall St · 1d ago
Peek Under The Hood: VTV Has 17% Upside
NASDAQ · 3d ago
Is STERIS Stock Underperforming the Nasdaq?
Barchart · 3d ago
Daily Dividend Report: MA,FULT,ZBH,WOR,HTLD
NASDAQ · 4d ago
Zimmer Biomet Holdings Is Maintained at Hold by Truist Securities
Dow Jones · 4d ago
Zimmer Biomet Holdings Price Target Raised to $118.00/Share From $117.00 by Truist Securities
Dow Jones · 4d ago
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $118
Benzinga · 4d ago
Zimmer Biomet price target raised to $118 from $117 at Truist
TipRanks · 4d ago
Zimmer Biomet declares $0.24 dividend
Seeking Alpha · 4d ago
*Zimmer Biomet Announces Quarterly Dividend of 24c for 4Q 2024 >ZBH
Dow Jones · 4d ago
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
PR Newswire · 4d ago
Press Release: Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Dow Jones · 4d ago
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks?
Barchart · 4d ago
Tesla upgraded, MongoDB initiated: Wall Street’s top analyst calls
TipRanks · 5d ago
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 5d ago
Zimmer Biomet Holdings Price Target Raised to $128.00/Share From $125.00 by JP Morgan
Dow Jones · 5d ago
Zimmer Biomet Holdings Raised to Overweight From Neutral by JP Morgan
Dow Jones · 5d ago
JP Morgan Upgrades Zimmer Biomet Holdings to Overweight, Raises Price Target to $128
Benzinga · 5d ago
Zimmer Biomet Holdings: Positioned for Growth with New Product Strategies Despite 2024 Challenges
TipRanks · 5d ago
Zimmer Biomet upgraded to Overweight from Neutral at JPMorgan
TipRanks · 5d ago
More
Webull provides a variety of real-time ZBH stock news. You can receive the latest news about Zimmer Biomet through multiple platforms. This information may help you make smarter investment decisions.
About ZBH
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.